glucose, (beta-d)-isomer has been researched along with Apnea, Obstructive Sleep in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Bai, XY; Sun, Q; Tang, Y; Zhang, M; Zhou, QL; Zhou, YF | 1 |
Eliasson, B; Inzucchi, SE; Johansen, OE; Kasai, T; Marx, N; Neeland, IJ; Wanner, C; Wojeck, BS; Yaggi, HK; Zinman, B; Zwiener, I | 1 |
Inzucchi, SE; Johansen, OE; Kasai, T; Neeland, IJ; Wojeck, BS; Yaggi, HK | 1 |
Brikman, S; Dori, G | 1 |
2 trial(s) available for glucose, (beta-d)-isomer and Apnea, Obstructive Sleep
Article | Year |
---|---|
Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study.
Topics: Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Sleep; Sleep Apnea, Obstructive; Treatment Outcome | 2019 |
The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial.
Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucosides; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Prevalence; Risk Factors; Sleep; Sleep Apnea, Obstructive; Treatment Outcome | 2020 |
2 other study(ies) available for glucose, (beta-d)-isomer and Apnea, Obstructive Sleep
Article | Year |
---|---|
Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007-3015.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Sleep Apnea, Obstructive | 2021 |
Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007-3015.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Sleep Apnea, Obstructive | 2021 |